![](/img/cover-not-exists.png)
Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an at1-receptor blocker in hypertensive patients
Alan H. Gradman, Roland E. Schmieder, Robert L. Lins, Yanntong Chiang, Martin P. BedigianVolume:
17
Year:
2004
Language:
english
Pages:
1
DOI:
10.1016/j.amjhyper.2004.03.279
File:
PDF, 42 KB
english, 2004